Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapy

Jinling Jiang, Tao Ma, Wenqi Xi, Chen Yang, Junwei Wu, Chenfei Zhou, Nan Wang, Zhenggang Zhu, Jun Zhang
  • Cancer Management and Research, September 2019, Taylor & Francis
  • DOI: 10.2147/cmar.s211089

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/cmar.s211089

The following have contributed to this page: Professor JUN ZHANG